More

• UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test Wednesday, 19 Jun 2013 | 2:55 AM ET

  *Onglyza fails to show cardiovascular benefit in study. *Positive results might have added $1 bln to peak sales. LONDON, June 19- AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals.

• Early Glance: Pharmaceuticals companies Tuesday, 18 Jun 2013 | 10:21 AM ET

  Baxter International Inc. rose$. 11 or. 2 percent, to $70.84. Bristol-Myers Squibb Co. rose$. 28 or. 6 percent, to $46.72. Hospira rose$. 10 or. 3 percent, to $36.52.

• Early Glance: Pharmaceuticals companies Monday, 17 Jun 2013 | 10:30 AM ET

  Baxter International Inc. rose$. 39 or. 6 percent, to $70.99. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $46.95. Hospira rose$. 36 or 1.0 percent, to $36.60.

• Codexis climbs on Chemtex production milestone Friday, 14 Jun 2013 | 2:55 PM ET

  NEW YORK-- Shares of Codexis Inc. jumped Friday after the company said it reached an important milestone in development of detergent alcohols made from biomass. THE SPARK: Codexis and its partner Chemtex said they have scaled up production of CodeXol detergent alcohols.

• Midday Glance: Pharmaceuticals companies Friday, 14 Jun 2013 | 1:28 PM ET

  Baxter International Inc. rose$. 08 or. 1 percent, to $70.83. Bristol-Myers Squibb Co. fell$. 23 or. 5 percent, to $46.94. Hospira fell$. 12 or. 3 percent, to $36.34.

• UPDATE 1-Lilly halts Alzheimer's drug trial due to liver problems Thursday, 13 Jun 2013 | 6:27 PM ET

  June 13- Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to find a treatment that can slow or cure the memory-robbing condition.

• Early Glance: Pharmaceuticals companies Thursday, 13 Jun 2013 | 10:22 AM ET

  Baxter International Inc. fell$. 01 or percent, to $69.74. Bristol-Myers Squibb Co. fell$. 09 or. 2 percent, to $46.48. Hospira fell$. 05 or. 1 percent, to $35.20.

• Midday Glance: Pharmaceuticals companies Wednesday, 12 Jun 2013 | 1:17 PM ET

  Baxter International Inc. rose$. 15 or. 2 percent, to $69.92. Bristol-Myers Squibb Co. fell$. 17 or. 4 percent, to $47.12. Hospira fell$. 61 or 1.7 percent, to $35.47.

• Early Glance: Pharmaceuticals companies Friday, 7 Jun 2013 | 10:26 AM ET

  Baxter International Inc. rose$. 70 or 1.0 percent, to $70.22. Bristol-Myers Squibb Co. rose$. 23 or. 5 percent, to $47.23. Hospira rose$. 62 or 1.8 percent, to $35.65.

• Early Glance: Pharmaceuticals companies Thursday, 6 Jun 2013 | 10:29 AM ET

  Baxter International Inc. fell$. 04 or. 1 percent, to $68.80. Bristol-Myers Squibb Co. rose$. 58 or 1.3 percent, to $46.75. Hospira rose$. 27 or. 8 percent, to $34.76.

• ANALYSIS-New cancer breakthroughs add pressure to control costs Wednesday, 5 Jun 2013 | 1:00 AM ET

  They included drugs from Bristol-Myers Squibb and Merck& Co that shrank tumors in patients with advanced melanoma and lung cancer. Citigroup analysts expect such "immunotherapies" to cost around $110,000 in the United States for a year's worth of treatment and $80,000 in the rest of the world, generating sales of $35 billion a year in the next 10 years.

• NYMEX-Oil eases after dollar-led rebound, holds above $93/bbl Monday, 3 Jun 2013 | 8:03 PM ET

  TOKYO, June 4- U.S. oil edged lower on Tuesday but held above $93 per barrel, as worries about slack demand weighed on prices after a late rebound the previous day on a slump in the dollar. *NYMEX crude for July delivery was down 27 cents at $93.18 a barrel by 2344 GMT, after settling up $1.48 at $93.45 on Monday.

• US STOCKS-Wall St ends higher on stimulus views, Merck gains Monday, 3 Jun 2013 | 4:35 PM ET

  NEW YORK, June 3- U.S. stocks rose on Monday, helped by weaker-than-expected factory activity that supported views the Federal Reserve will keep economic stimulus in place, while gains in Merck& Co lifted drug companies.

• US STOCKS SNAPSHOT-Wall St ends higher in late rebound Monday, 3 Jun 2013 | 4:01 PM ET

  NEW YORK, June 3- U.S. stocks rose on Monday as weaker-than-expected factory activity last month supported views that the Federal Reserve will need to keep economic stimulus in place, while gains in Merck& Co's lifted drug companies. Intel Corp helped the Nasdaq turn positive in the final hour of trading, rising 3.9 percent to $25.23.

• Bristol and Merck Shares Surge on Cancer Drug News Monday, 3 Jun 2013 | 3:32 PM ET

  

  Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.

• GLOBAL MARKETS-Stocks struggle, dollar down; U.S. manufacturing slips Monday, 3 Jun 2013 | 3:06 PM ET

  NEW YORK, June 3- Stocks and the U.S. dollar struggled on Monday in a seesaw session after data showed U.S. manufacturing activity contracted for the first time in six months, raising concerns about the health of the U.S. recovery. The Institute for Supply Management reported that its gauge for new orders slipped and said there was less demand for exports.

• US STOCKS-S&P 500 flat after poor factory data, Merck lifts Dow Monday, 3 Jun 2013 | 2:42 PM ET

  NEW YORK, June 3- The S&P 500 index was little changed on Monday as weaker-than-expected factory activity last month fed worries the economic recovery was struggling, while gains in Merck& Co's shares lifted the Dow and other drug companies.

• Midday Movers: PCAR, YELP, P & More Monday, 3 Jun 2013 | 2:27 PM ET

  

  Take a look at some of Monday's midday movers:

• US STOCKS-S&P dips after data but Merck lifts Dow Monday, 3 Jun 2013 | 12:43 PM ET

  NEW YORK, June 3- U.S. stocks were mostly lower in choppy trade on Monday as the latest data on manufacturing continued to paint a mixed picture on the strength of the economy. The S&P 500 fluctuated between losses and gains but the Dow managed to post a slight gain, boosted by a 5.3 percent jump in Merck& Co Inc..

• GLOBAL MARKETS-Stocks, dollar fall as U.S. manufacturing contracts Monday, 3 Jun 2013 | 11:53 AM ET

  *Dollar falls below 100 yen, lowest since early May. NEW YORK, June 3- Stocks and the dollar declined on Monday in volatile trading after a U.S. report on domestic manufacturing activity showed a contraction for the first time in six months, raising concerns about the health of the U.S. recovery.